Phase 1/2 Study of Carfilzomib, Pomalidomide, and Dexamethasone with and Without Daratumumab in Relapsed Multiple MyelomaBenjamin A. Derman,Jeffrey Zonder,Donna Reece,Craig Cole,Jesus Berdeja,Andrew T. Stefka,Ajay Major,Andrew Kin,Kent Griffith,Jagoda Jasielec,Andrzej J. JakubowiakBlood Advances(2023)引用 2|浏览21AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要